US Bancorp DE Raises Position in USANA Health Sciences, Inc. $USNA

US Bancorp DE boosted its stake in USANA Health Sciences, Inc. (NYSE:USNAFree Report) by 13.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,611 shares of the company’s stock after buying an additional 535 shares during the period. US Bancorp DE’s holdings in USANA Health Sciences were worth $124,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Teacher Retirement System of Texas bought a new stake in shares of USANA Health Sciences during the first quarter valued at approximately $888,000. GAMMA Investing LLC increased its position in shares of USANA Health Sciences by 49,082.4% during the first quarter. GAMMA Investing LLC now owns 8,361 shares of the company’s stock valued at $225,000 after acquiring an additional 8,344 shares in the last quarter. Millennium Management LLC bought a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $633,000. Exchange Traded Concepts LLC increased its position in shares of USANA Health Sciences by 7.1% during the first quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company’s stock valued at $248,000 after acquiring an additional 606 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after acquiring an additional 55,059 shares in the last quarter. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 1,058 shares of the firm’s stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total value of $30,787.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider David Mulham Mulham sold 3,515 shares of USANA Health Sciences stock in a transaction on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the sale, the insider owned 9,260 shares of the company’s stock, valued at $280,207.60. The trade was a 27.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,364 shares of company stock worth $342,536 over the last three months. Corporate insiders own 0.63% of the company’s stock.

USANA Health Sciences Stock Performance

USNA opened at $30.39 on Monday. The stock has a market cap of $555.23 million, a price-to-earnings ratio of 16.88, a price-to-earnings-growth ratio of 0.97 and a beta of 0.61. USANA Health Sciences, Inc. has a fifty-two week low of $23.10 and a fifty-two week high of $41.83. The firm’s fifty day moving average is $30.90 and its 200 day moving average is $29.56.

USANA Health Sciences (NYSE:USNAGet Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. The business had revenue of $235.85 million for the quarter, compared to analysts’ expectations of $225.20 million. On average, equities research analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, May 22nd.

Get Our Latest Analysis on USNA

USANA Health Sciences Company Profile

(Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Featured Articles

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNAFree Report).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.